Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Morgan

Showing results (191-200 of 297) with videos related to

Pageof 30
Sort By:
Experimental Hematology|January 25, 2012
Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignanciesWichai Chinratanalab, Nishitha Reddy, John P Greer, et al.
Frontiers in Aging Neuroscience|June 16, 2025
Blood essential trace elements and Alzheimer's disease biomarkers in midlifeXin Wang, Kelly M Bakulski, Carrie A Karvonen-Gutierrez, et al.
The British Journal of Radiology|September 22, 2020
A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancerMuhammad Shahid Iqbal, Nick West, Neil Richmond, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2009
Suppression of amyloid deposition leads to long-term reductions in Alzheimer's pathologies in Tg2576 miceRachel A Karlnoski, Arnon Rosenthal, Dione Kobayashi, et al.
Oral Oncology|December 8, 2020
The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinomaHelen Adderley, Samuel Rack, Brindley Hapuarachi, et al.
Arthritis Research & Therapy|June 9, 2017
Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapseMatthew David Morgan, Matthew Szeto, Michael Walsh, et al.
Oncotarget|October 17, 2015
Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapyJiang Cheng, Xiaoyang Lin, David Morgan, et al.
Journal of Clinical Gastroenterology|November 10, 2021
Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel DiseaseElisa Buffone, Shaan Gupta, Bashaar Al Ibrahim, et al.
Journal of Neuroscience Research|September 21, 2004
Lovastatin modulation of microglial activation via suppression of functional CD40 expressionKirk P Townsend, Doug R Shytle, Yun Bai, et al.
European Journal of Immunology|February 3, 2005
CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptideKirk P Townsend, Terrence Town, Takashi Mori, et al.
Pageof 30

Showing results (191-200 of 297) with videos related to

Sort By:
Pageof 30
Experimental Hematology|January 25, 2012
Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignanciesWichai Chinratanalab, Nishitha Reddy, John P Greer, et al.
Frontiers in Aging Neuroscience|June 16, 2025
Blood essential trace elements and Alzheimer's disease biomarkers in midlifeXin Wang, Kelly M Bakulski, Carrie A Karvonen-Gutierrez, et al.
The British Journal of Radiology|September 22, 2020
A systematic review and practical considerations of stereotactic body radiotherapy in the treatment of head and neck cancerMuhammad Shahid Iqbal, Nick West, Neil Richmond, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2009
Suppression of amyloid deposition leads to long-term reductions in Alzheimer's pathologies in Tg2576 miceRachel A Karlnoski, Arnon Rosenthal, Dione Kobayashi, et al.
Oral Oncology|December 8, 2020
The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinomaHelen Adderley, Samuel Rack, Brindley Hapuarachi, et al.
Arthritis Research & Therapy|June 9, 2017
Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapseMatthew David Morgan, Matthew Szeto, Michael Walsh, et al.
Oncotarget|October 17, 2015
Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapyJiang Cheng, Xiaoyang Lin, David Morgan, et al.
Journal of Clinical Gastroenterology|November 10, 2021
Week 2 Adalimumab Levels Predict Short-term Clinical Remission in Patients With Inflammatory Bowel DiseaseElisa Buffone, Shaan Gupta, Bashaar Al Ibrahim, et al.
Journal of Neuroscience Research|September 21, 2004
Lovastatin modulation of microglial activation via suppression of functional CD40 expressionKirk P Townsend, Doug R Shytle, Yun Bai, et al.
European Journal of Immunology|February 3, 2005
CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptideKirk P Townsend, Terrence Town, Takashi Mori, et al.
Pageof 30